Sale!

SPTA1 Gene Spherocytosis Type 3 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SPTA1 gene spherocytosis type 3 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SPTA1 gene, which are associated with Hereditary Spherocytosis type 3. This condition is a form of hereditary spherocytosis, a disorder characterized by anemia, jaundice, and an enlarged spleen, due to the production of abnormally shaped red blood cells. The test plays a crucial role in confirming the diagnosis, enabling targeted treatment and management strategies for affected individuals.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the SPTA1 gene to detect any genetic anomalies that may lead to the condition. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the gene. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for personalized medical care and informed decision-making regarding their health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SPTA1 Gene Spherocytosis Type 3 Genetic Test

At DNA Labs UAE, we offer the SPTA1 Gene Spherocytosis Type 3 Genetic Test. This test is designed to identify mutations or variants in the SPTA1 gene that may be associated with hereditary spherocytosis type 3, a type of hemolytic anemia that affects the red blood cells and leads to their premature destruction.

Test Details

Test Name: SPTA1 Gene Spherocytosis Type 3 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SPTA1 Gene Spherocytosis Type 3 NGS Genetic DNA Test gene SPTA1

About the SPTA1 Gene and NGS Technology

The SPTA1 gene is associated with hereditary spherocytosis type 3. By performing an NGS genetic test on the SPTA1 gene, healthcare providers can identify any mutations or variants that may be present in an individual’s DNA. This information can help in diagnosing hereditary spherocytosis type 3 and guiding treatment decisions.

NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. In the context of genetic testing, NGS can be used to identify mutations or variants in the SPTA1 gene that may be associated with hereditary spherocytosis type 3.

Importance of Genetic Testing

It is important to note that genetic testing should always be performed under the guidance of a healthcare professional, as the results need to be interpreted in the context of the individual’s medical history and other factors. Genetic testing can provide valuable information for diagnosing hereditary spherocytosis type 3 and guiding treatment decisions.

For more information about the SPTA1 Gene Spherocytosis Type 3 Genetic Test or to schedule an appointment, please contact DNA Labs UAE.

Test Name SPTA1 Gene Spherocytosis type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SPTA1 Gene Spherocytosis type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SPTA1 Gene Spherocytosis type 3 NGS Genetic DNA Test gene SPTA1
Test Details

The SPTA1 gene is associated with a condition called hereditary spherocytosis type 3. This condition is a type of hemolytic anemia, which means it affects the red blood cells and leads to their premature destruction.

NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. In the context of genetic testing, NGS can be used to identify mutations or variants in the SPTA1 gene that may be associated with hereditary spherocytosis type 3.

By performing an NGS genetic test on the SPTA1 gene, healthcare providers can identify any mutations or variants that may be present in an individual’s DNA. This information can help in diagnosing hereditary spherocytosis type 3 and guiding treatment decisions.

It is important to note that genetic testing should always be performed under the guidance of a healthcare professional, as the results need to be interpreted in the context of the individual’s medical history and other factors.